CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Brooklyn Immunotherapeutics

For profitWebsite ↗

Also known as: Brooklyn ImmunoTherapeutics, LLC

Phase 1Phase 2Phase 3Phase 4

First clinical trial

Jun 1, 2018

Last known activity

Jul 15, 2020

Acquired by IRX Therapeutics → Brooklyn Immunotherapeutics → IRX Therapeutics → Brooklyn Immunotherapeutics → IRX Therapeutics → Brooklyn Immunotherapeutics → IRX Therapeutics → Brooklyn Immunotherapeutics → IRX Therapeutics → Brooklyn Immunotherapeutics → IRX Therapeutics → Brooklyn Immunotherapeutics → IRX Therapeutics → Brooklyn Immunotherapeutics → IRX Therapeutics → Brooklyn Immunotherapeutics → IRX Therapeutics → Brooklyn Immunotherapeutics → IRX Therapeutics → Brooklyn Immunotherapeutics → IRX Therapeutics → Brooklyn Immunotherapeutics → IRX Therapeutics → Brooklyn Immunotherapeutics → IRX Therapeutics on Nov 17, 2018

Timeline

2010s

  1. Jun 1, 2018

    Brooklyn Immunotherapeutics— Founded

  2. Nov 7, 2018

    IRX Therapeutics— Acquired

  3. Nov 17, 2018

    IRX Therapeutics— Acquired By

  4. Nov 17, 2018

    IRX Therapeutics— Now

2020s

  1. Jun 17, 2021

    Novellus Therapeutics— Acquired

Drugs by trial phase (10 distinct, 9 trials)

Indications

Studied for

Subsidiaries (2 direct, 38 total across the full acquisition tree)

Recent trials (3)

Details

Founded
Brooklyn, NY, US Jun 1, 2018
Last known activity
Jul 15, 2020